Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Concert Pharmaceutic (CNCE)

Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CNCE, ISO, TIG PR Newswire - Wed Feb 15, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CNCE : 8.37 (+0.12%)
TIG : 6.16 (+0.16%)
ISO : 0.7616 (+2.78%)
Concert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia Areata Business Wire - Wed Feb 15, 2023

Concert Pharmaceuticals, Inc. today announced that, after a recent review of deuruxolitinib clinical data by the U.S. Food and Drug Administration (FDA), the FDA determined that deuruxolitinib will maintain...

CNCE : 8.37 (+0.12%)
CNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders Business Wire - Mon Feb 13, 2023

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) to Sun Pharmaceutical Industries Limited is fair to Concert shareholders....

CNCE : 8.37 (+0.12%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CNCE, AQUA, LPTX, ALR PR Newswire - Tue Feb 7, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CNCE : 8.37 (+0.12%)
AQUA : 49.88 (+0.95%)
ALR : 1.3200 (+0.76%)
LPTX : 2.0500 (+368.57%)
SHAREHOLDER ALERT: Weiss Law Reminds AQUA, LPTX, CNCE, and ALBO Shareholders About Its Ongoing Investigations PR Newswire - Mon Feb 6, 2023

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

AQUA : 49.88 (+0.95%)
CNCE : 8.37 (+0.12%)
ALBO : 44.15 (-0.23%)
LPTX : 2.0500 (+368.57%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALBO, CNCE, AQUA, LPTX PR Newswire - Tue Jan 31, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CNCE : 8.37 (+0.12%)
AQUA : 49.88 (+0.95%)
ALBO : 44.15 (-0.23%)
LPTX : 2.0500 (+368.57%)
SHAREHOLDER ALERT: Weiss Law Reminds AQUA, LPTX, CNCE, and ALBO Shareholders About Its Ongoing Investigations PR Newswire - Mon Jan 30, 2023

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

AQUA : 49.88 (+0.95%)
CNCE : 8.37 (+0.12%)
ALBO : 44.15 (-0.23%)
LPTX : 2.0500 (+368.57%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HZN, ANGN, CNCE PR Newswire - Thu Jan 26, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CNCE : 8.37 (+0.12%)
ANGN : 1.0000 (+2.04%)
HZN : 1.7600 (unch)
SHAREHOLDER ALERT: Weiss Law Reminds LPTX, CNCE, ALBO, and CINC Shareholders About Its Ongoing Investigations PR Newswire - Mon Jan 23, 2023

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

CNCE : 8.37 (+0.12%)
CINC : 29.06 (-0.48%)
ALBO : 44.15 (-0.23%)
LPTX : 2.0500 (+368.57%)
Moore Kuehn Encourages NVCN, VLTA, CNCE, and ANGN Investors to Contact Law Firm PR Newswire - Sat Jan 21, 2023

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

CNCE : 8.37 (+0.12%)
NVCN : 30.03 (+1.66%)
ANGN : 1.0000 (+2.04%)
VLTA : 0.8590 (-0.01%)

Barchart Exclusives

AbbVie Just Sparked a 46% Rally in Apogee. Here’s Why This $10.9 Billion Deal Could Be a Win for AbbVie Investors. Barchart - 3 minutes ago
Apogee’s rally may be over, but AbbVie’s upside from the deal could just be getting started. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.